CN104872521A - 一种有助于提高性生活质量的天然保健食品及其生产工艺 - Google Patents
一种有助于提高性生活质量的天然保健食品及其生产工艺 Download PDFInfo
- Publication number
- CN104872521A CN104872521A CN201510306159.0A CN201510306159A CN104872521A CN 104872521 A CN104872521 A CN 104872521A CN 201510306159 A CN201510306159 A CN 201510306159A CN 104872521 A CN104872521 A CN 104872521A
- Authority
- CN
- China
- Prior art keywords
- natural health
- sterilizing
- raw material
- product
- care food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 235000013305 food Nutrition 0.000 title abstract description 9
- 230000001568 sexual effect Effects 0.000 title abstract description 9
- 230000002349 favourable effect Effects 0.000 title abstract 2
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 22
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 16
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 14
- 235000007320 Avena fatua Nutrition 0.000 claims abstract description 11
- 240000000143 Turnera diffusa Species 0.000 claims abstract description 11
- 235000004952 turnera diffusa Nutrition 0.000 claims abstract description 11
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 9
- 241000660877 Coridius Species 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 32
- 230000001954 sterilising effect Effects 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 19
- 210000001320 hippocampus Anatomy 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 11
- 241001647031 Avena sterilis Species 0.000 claims description 10
- 235000004535 Avena sterilis Nutrition 0.000 claims description 10
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 10
- 239000004833 fish glue Substances 0.000 claims description 10
- 244000241872 Lycium chinense Species 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000013590 bulk material Substances 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 239000006227 byproduct Substances 0.000 claims 1
- 238000005538 encapsulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 4
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 244000075850 Avena orientalis Species 0.000 abstract 1
- 241000206672 Gelidium Species 0.000 abstract 1
- 241000283220 Odobenus rosmarus Species 0.000 abstract 1
- 235000005373 Uvularia sessilifolia Nutrition 0.000 abstract 1
- 229910003460 diamond Inorganic materials 0.000 abstract 1
- 239000010432 diamond Substances 0.000 abstract 1
- 108010059642 isinglass Proteins 0.000 abstract 1
- 229910052627 muscovite Inorganic materials 0.000 abstract 1
- 230000036299 sexual function Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 13
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 8
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 7
- 229940094720 viagra Drugs 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 208000012201 sexual and gender identity disease Diseases 0.000 description 3
- 208000015891 sexual disease Diseases 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229930003347 Atropine Natural products 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- 208000010038 Ischemic Optic Neuropathy Diseases 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030924 Optic ischaemic neuropathy Diseases 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- -1 carrotene Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000019244 cryptoxanthin Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 201000002761 non-arteritic anterior ischemic optic neuropathy Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000508786 Arrhenatherum elatius Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 241000209761 Avena Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000578422 Graphosoma lineatum Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001466007 Heteroptera Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 101150098694 PDE5A gene Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000000340 Solanum pseudocapsicum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 240000004482 Withania somnifera Species 0.000 description 1
- 235000001978 Withania somnifera Nutrition 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940099908 multivitamin and calcium Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- MMCWRTZSCVUETH-GAEVZRCVSA-N n-[[(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(1h-benzimidazol-2-yl)acetamide Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CNC(=O)CC=2NC3=CC=CC=C3N=2)O1 MMCWRTZSCVUETH-GAEVZRCVSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000036259 sexual stimuli Effects 0.000 description 1
- 229960002639 sildenafil citrate Drugs 0.000 description 1
- 210000000162 simple eye Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种有助于提高性生活质量的天然保健食品。它由下述重量份的原料经低温工艺制备而成:雪钻野燕麦、枸杞子、海马、九香虫、达米阿那树叶、鱼胶和甜叶菊提取物。本发明采用多种纯天然原料组方,超低温工艺进行生产,避免了营养成分的流失,同时生产的产品天然、无毒副作用,适用于性功能低下的人群或需要提高性生活质量的人群服用。
Description
技术领域
本发明涉及一种保健食品及其生产工艺,属于保健食品技术领域。
背景技术
目前,市场上出售的有助于提高性生活质量的保健品(或药物)的品种繁多,有以中草药为原料生产的,有以西药为原料生产的。中草药为原料生产这类产品时,采用蒸煮、炮制、炙制等方法。由于高温的作用,使这类原料中的有效成份受到损失,使产品作用下降。原料中的维生素类、氨基酸类营养成分都有不同程度的损失。我国传统的补肾中药枸杞经过高温处理后,其中所含的胡萝卜素、核黄素、V1、V12、天门冬氨酸、脯氨酸、丙氨酸、亮氨酸等成分,损失高达近50%以上。而一些西药类制品,虽然提高性生活质量效果明显,但又产生不少副作用。如市场上经常即出现的美国产的“万艾可”,主要成份为枸橼酸西地那非。它是全球第一个口服PDE5(5型磷酸二酯酶抑制剂),用于治疗男性勃起功能障碍,但其缺陷是:正在服用任何剂型硝酸酯类药物(包括常用于降血压的硝酸甘油)的患者,绝对不能同时服用万艾可。如果服用万艾可的同时服用硝酸酯类药,服用者血压可能会突然下降,甚至危及生命,因此限制了万艾可的使用人群。万艾可还会产生单眼或双眼视力突然下降(非动脉炎性前部缺血性视神经病变NAION)。万艾可常见的副作用还有头痛、面部潮红、胃部不适、视力异常、鼻塞、流鼻涕、背痛、恶心、皮疹、头晕等。大多数化学结构的助性药物都存在这类副作用。
发明内容
为了克服上述中西类补肾壮阳药物的不足,本发明提供了一种有助于提高性生活质量的天然保健食品。本发明采用多种纯天然原料组方,超低温工艺进行生产,避免了营养成分的流失,同时生产的产品天然、无毒副作用。
本发明的技术方案是:一种有助于提高性生活质量的天然保健食品,由下述重量份的原料经低温工艺制备而成:雪钻野燕麦10-40、枸杞子20-40、海马10-15、九香虫4-10、达米阿那树叶20-25、鱼胶5-10、甜叶菊提取物0.5-2。
其中,甜叶菊提取物的甜菊糖总甙含量≥80%。上述原料均为市售原料。
生产工艺:
(1)按重量份称取上述原料,加水浸泡透,研磨后过120-160目筛;
(2)将步骤(1)处理后的原料真空冷冻干燥,使其含水量≤5%;
(3)二次粉碎:将真空冷冻干燥后的块状材料粉碎,过120-160目筛;
(4)包装、密封后,产品进行钴-60灭菌。
优选的钴-60灭菌的工艺如下:将已密封好的粉状或片状产品置于钴-60灭菌装置内,以10KGy强度辐照灭菌5分钟以上;对已辐照的产品进行检查,发现包装有密封不严,或破损的要取出,不得出售。
适用人群及使用方法:适用于性功能低下的人群或需要提高性生活质量的人群,男、女均可服用,服用量每日2-4克。性功能低下者,连服10-20天即可提高性功能;普通人群,性生活前1-2小时服用,可提高性生活质量。
各原料及作用:
雪钻野燕麦:血钻野燕麦是是燕麦草科,燕麦属的植物。它是主产于阿拉伯国家的一种野燕麦(麦田杂草)。实践证明,其成分具有有效提高男性生殖器充血量、女性分泌物增加的效果。雪钻野燕麦富含多种矿物质及微量元素,逐步恢复男性中枢神经和性器官微血管的活性,调节荷尔蒙,促进性器官的活性。
枸杞子:以我国夏产为上品,含有人体有益的多种成分,如含甜菜碱(betane)、阿托品(atropine)、天仙子胺(gyoscyamine)、、玉蜀黍黄素(zeaxanthin)、酸浆红素(physalein)、隐黄质(cryptoxanthin)、东莨菪素(scopoletin)、胡萝卜素、核黄素、烟酸、维生素B1、B2、C,种子含氨基酸、天门冬酸、脯氨酸、丙氨酸、亮氨酸等。枸杞子是我国传统的补肾壮阳的药食两用材料,也是被现代医学证明的有助于男女性内分泌、神经、生殖系统健康的珍贵资源,不阴不燥,适量食用,无任何毒副作用。
海马:海马是一种小型海洋动物。大西洋、欧洲、太平洋、澳大利亚及我国海域有产,产量较多,足以满足工艺要求。海马含人体必需的多种氨基酸、胶原蛋白、钙、镁、锌、铁等对人体有益的物质,有补肾壮阳、舒筋活血、镇静安神、强身健体等作用,是古配方及现代医学健身强体备受欢迎的材料。在我国的中药配方中,海马是一种名贵中药,主要用于补救男性性生活质量不足,因而备受男性欢迎。海马已成为男性提高性生活质量和生殖能力,常被入方的珍贵药材。海马食用对人体无任何不良影响,适应于大多数人群。
九香虫:即半翅目,异翅亚目,蝽科的瓜黑蝽。我国大部分地区均产,如云南、四川、贵州、广西、河南、安徽、江苏、浙江、福建、台湾、广东等地。对脾肾阳虚、腰酸乏力、阳痿、遗尿症有显著疗效。虫体中含有对人体有益的多种元素,如硬脂酸、棕榈酸、油酸、蛋白质等。
达米阿那树叶(透纳树叶):达米阿那(Damiana)是墨西哥和中北美独有的一种绿色矮树,西班牙传教士最早记载,墨西哥印第安人喝煮开的达米阿那树叶作为一种壮阳药使用。它的催情功效可能要归功于它温和的刺激中央神经系统和荷尔蒙系统,增强了身体的敏感度和精力,还可轻微的刺激男性的尿道,进而让阴茎更敏感,而对性刺激更有反应。
鱼胶:即鱼鳔(辅助呼吸器官)的干制品,富胶质,故名鱼胶。它的主要成分为高级胶原蛋白、多种维生素及钙、锌、铁、硒等多种微量元素。其蛋白质含量高达84.2%,脂肪仅为0.2%,是理想的高蛋白低脂肪食品。是人体补充、合成蛋白质的原料,且易于吸收和利用。本发明中鱼胶起到强补人体所需的各种微量元素,作为粘合剂,利于压片成型的作用。
甜叶菊:甜叶菊原产地为南美,我国几十年前引种成功,已进入大面积种植阶段。甜叶菊提取物(甜菊糖苷)甜度是蔗糖的300倍以上。本产品中仅加入0.5-2%即可达到口味适宜的程度。甜叶菊提取物改善了产品口感,但又不被人体吸收,热当量只有产品的1/300,一些不宜食糖的人,可以不限量食用,扩大了产品的使用范围。
本发明加水浸泡的目的是,使原料粉碎至所需要的细度,又不至因干燥研磨产生高温破坏原料中的有效成分。实验证明,当上述原料不加水细化时,磨膛温度高达100℃以上,甚至焦糊,显然会破坏原料中的有效成分,而以水浸泡后的原料,研磨过程中仍保持常温,不会破坏原料中的有效成分。
目前,多数食品加工工艺采用高温灭菌的方式。如巴氏灭菌温度在95℃以上,灭菌10分钟左右;瞬时灭菌温度高达100-135℃,灭菌数分钟。在巴氏灭菌和瞬时灭菌的高温长时间作用下,原料中的营养成分被破坏,尤其是氨基酸类、维生素类、多糖类、苷类等成分几乎多数损失掉。而这些物质,正是起到关键作用的有益成分。因而,本工艺采用了与上述灭菌方式完全不同的方法——真空低温灭菌方式。操作温度在-10℃~-40℃,上述营养成分在本工艺低温范围内不分解、不变质,并保留了活性物质,使本工艺产品具备原料特有的品质。本发明采用真空冷冻干燥的方法,使原物质水分仅存5%以下,使酵母等多数细菌、病毒等无法生存、繁殖而达到灭菌的目的。
本发明先将细化至120-160目的上述原料冷冻至-10℃~-40℃成固态,然后在真空(1.3-13Pa)下使水分直接升华成气态,最终使原料脱水至干燥状态。干燥后的原料呈块状,必须进行二次粉碎至120-160目,以便于服用,也可压成片状。
本发明将粉末状产品包装,或将其压成片状后进入灭菌程序。本工艺采用钴-60灭菌方式进行。钴-60灭菌是近几十年灭菌行业的新兴产业。本发明采用10KGy强度。在此强度下,γ射线对原料中有效成分损失可忽略不计。
本工艺是把已密封好的产品进行辐照灭菌的,在γ射线一定强度辐照下,细菌病毒被杀死,可达到对人体无害的标准。同时,外部微生物又不能进入包装内,而延长了保质期。本工艺产品的保质期可达7-12月以上。
本发明的有益效果是:
(1)本发明全部采用纯天然材料,这些材料是人们日常食用的食品材料或药食两用的材料(如枸杞子),对人体无害;只要按一定数量服用,无副作用,这是严格区别于万艾可这类化学产品的显著特点;
(2)本发明以雪钻野燕麦、枸杞子、海马、九香虫、达米阿那树叶和鱼胶组方,各材料之间相协同,有助于男性勃起、女性分泌物增多以及提高男女身体的敏感度,从而达到提高性生活质量的目的;同时所用材料性质温和,且各材料之间相融合,对消费者是安全的,适合普通人群服用;
(3)本发明的生产工艺是在低温下进行,营养成分不会破坏;同时在10kGy射线辐照灭菌,无放射物质残留,对人体是安全的,消费者可以放心使用;经检测原料中的有效成分,如苷类、核酸、氨基酸、维生素类、甜菜碱、胡萝卜素、天仙子碱等有益物质,没有发生质变或数量的变化;也就是说,辐照灭菌最大限度的保持了原料中的有效成分,增加了产品的功效;由于密封后灭菌,微生物无与产品接触的机会而延长了保质期;
(4)本工艺采用甜叶菊提取物为产品口味的改良材料,甜叶菊提取物的热当量低,一些不宜食糖的人,可以不限量食用,扩大了产品的使用范围;但是甜叶菊提取物的耐热性差,高温制作是不可使用的;本发明整个工艺过程(包括细化、熟化、灭菌等全部工艺过程)不涉及高温。在10KGy以下强度辐照灭菌又不会使甜叶菊提取物成分发生变化,而提高了产品的品质和安全性;
(5)本发明采用的原料上,即全部为天然产品,对人体无任何毒副作用。但含人体必需的多种营养物质。因而本产品是一种强化进补的食品组合。如鱼胶为我国八珍之一。在出现体力消耗多、体弱、性功能弱的状况时,本产品也是一种较全面的补品,为本产品区别于化学制品类壮阳药物的显著特征,适宜各类人群。
具体实施方式
实施例1
配比:雪钻野燕麦400g、枸杞子200g、海马100g、九香虫45g、达米阿那树叶200g、鱼胶50g、甜叶菊提取物5g。
生产工艺:
(1)按上述重量称取各原料,加水浸泡透,研磨后过120目筛;
(2)将上述研磨过的原料进行真空冷冻干燥(-40℃),使其含水量≤5%;
(3)二次粉碎:经过干燥的材料为块状,不规则,易碎成粉末,以普通机磨粉碎,使其通过120目筛;
(4)包装:粉状产品装袋,每袋2g;片状装包,每片1g。封紧口,不得漏气破损。
(5)灭菌:钴-60灭菌,10KGy强度辐照灭菌5分钟以上。
以上制得产品1000g,每包2g,可制得500包,以水冲服;每片1g,可制得1000片,含化或吞咽服用。
上述产品经100人性功能低下的男性服用,每日2-4克,连服20天后进行统计,其中97人性功能恢复正常,其余3人有所改善。上述产品经100人普通人群在性生活前1小时服用(其中男性62人、女性38人),98人认为,性生活质量提高。
实施例2
配比:雪钻野燕麦350g、枸杞子200g、海马100g、九香虫40g、达米阿那树叶200g、鱼胶100g、甜叶菊提取物10g。
生产工艺:
(1)按上述重量称取各原料,加水浸泡透,研磨后过150目筛;
(2)将上述研磨过的原料进行真空冷冻干燥(-40℃),使其含水量≤5%;
(3)二次粉碎:经过干燥的材料为块状,不规则,易碎成粉末,以普通机磨粉碎,使其通过150目筛;
(4)包装:粉状产品装袋,每袋2g;片状装包,每片1g。封紧口,不得漏气破损。
(5)灭菌:钴-60灭菌,10KGy强度辐照灭菌5分钟以上。
以上制得产品1000g,每包2g,可制得500包,以水冲服;每片1g,可制得1000片,含化或吞咽服用。
实施例3
配比:雪钻野燕麦200g、枸杞子250g、海马150g、九香虫90g、达米阿那树叶200g、鱼胶100g、甜叶菊提取物10g。
制备方法:同实施例1。
Claims (5)
1.一种有助于提高性生活质量的天然保健食品,其特征是,由下述重量份的原料经低温工艺制备而成:雪钻野燕麦10-40、枸杞子20-40、海马10-15、九香虫4-10、达米阿那树叶20-25、鱼胶5-10、甜叶菊提取物0.5-2。
2.如权利要求1所述的一种有助于提高性生活质量的天然保健食品,其特征是,所述甜叶菊提取物的甜菊糖总甙含量≥80%。
3.如权利要求1或2所述的天然保健食品的生产工艺,其特征是,
(1)将原料加水浸泡透,研磨后过120-160目筛;
(2)将步骤(1)处理后的原料真空冷冻干燥,使其含水量≤5%;
(3)二次粉碎:将真空冷冻干燥后的块状材料粉碎,过120-160目筛;
(4)包装密封后,产品进行钴-60灭菌。
4.如权利要求3所述的生产工艺,其特征是,所述钴-60灭菌为:将产品置于钴-60灭菌装置内,以10KGy强度辐照灭菌5分钟以上。
5.如权利要求3所述的生产工艺,其特征是,所述真空冷冻干燥温度为-10℃~-40℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510306159.0A CN104872521A (zh) | 2015-06-05 | 2015-06-05 | 一种有助于提高性生活质量的天然保健食品及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510306159.0A CN104872521A (zh) | 2015-06-05 | 2015-06-05 | 一种有助于提高性生活质量的天然保健食品及其生产工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104872521A true CN104872521A (zh) | 2015-09-02 |
Family
ID=53940420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510306159.0A Pending CN104872521A (zh) | 2015-06-05 | 2015-06-05 | 一种有助于提高性生活质量的天然保健食品及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104872521A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107183295A (zh) * | 2017-06-20 | 2017-09-22 | 慧谷生命科技湖北有限公司 | 一种血钻野燕麦压片糖果 |
CN108939171A (zh) * | 2018-08-03 | 2018-12-07 | 孙廷柱 | 一种具有缩阴功能的可溶性安全套及其生产方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115654A (zh) * | 1994-07-19 | 1996-01-31 | 于延春 | 一种益肾口服药物及制备方法 |
CN101284115A (zh) * | 2008-05-30 | 2008-10-15 | 连德峰 | 补肾强体丹及其生产工艺 |
CN101361930A (zh) * | 2008-08-25 | 2009-02-11 | 李富祥 | 一种男性功能滋补保健品及其制备方法 |
CN101810763A (zh) * | 2010-04-20 | 2010-08-25 | 烟台新安男科医院 | 治疗男性不育和性功能障碍的中药制剂及其制备方法 |
CN101953852A (zh) * | 2010-09-16 | 2011-01-26 | 贵州信邦制药股份有限公司 | 一种抗凝血酶制剂及其制备方法 |
CN103356751A (zh) * | 2013-07-16 | 2013-10-23 | 李铁清 | 增强性功能、促进男性性器官再生长的提取物组合 |
CN104127446A (zh) * | 2014-07-01 | 2014-11-05 | 贵州黔坤生物制药有限公司 | 冬虫夏草菌丝湿法研磨、冷冻干燥获得菌丝粉的方法 |
CN104547467A (zh) * | 2015-01-29 | 2015-04-29 | 福建广生堂药业股份有限公司 | 一种具有补肾壮阳、治疗性功能障碍、延缓衰老的中药复方制剂及其应用 |
-
2015
- 2015-06-05 CN CN201510306159.0A patent/CN104872521A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115654A (zh) * | 1994-07-19 | 1996-01-31 | 于延春 | 一种益肾口服药物及制备方法 |
CN101284115A (zh) * | 2008-05-30 | 2008-10-15 | 连德峰 | 补肾强体丹及其生产工艺 |
CN101361930A (zh) * | 2008-08-25 | 2009-02-11 | 李富祥 | 一种男性功能滋补保健品及其制备方法 |
CN101810763A (zh) * | 2010-04-20 | 2010-08-25 | 烟台新安男科医院 | 治疗男性不育和性功能障碍的中药制剂及其制备方法 |
CN101953852A (zh) * | 2010-09-16 | 2011-01-26 | 贵州信邦制药股份有限公司 | 一种抗凝血酶制剂及其制备方法 |
CN103356751A (zh) * | 2013-07-16 | 2013-10-23 | 李铁清 | 增强性功能、促进男性性器官再生长的提取物组合 |
CN104127446A (zh) * | 2014-07-01 | 2014-11-05 | 贵州黔坤生物制药有限公司 | 冬虫夏草菌丝湿法研磨、冷冻干燥获得菌丝粉的方法 |
CN104547467A (zh) * | 2015-01-29 | 2015-04-29 | 福建广生堂药业股份有限公司 | 一种具有补肾壮阳、治疗性功能障碍、延缓衰老的中药复方制剂及其应用 |
Non-Patent Citations (1)
Title |
---|
魏红霞: "《植物百科》", 30 April 2015 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107183295A (zh) * | 2017-06-20 | 2017-09-22 | 慧谷生命科技湖北有限公司 | 一种血钻野燕麦压片糖果 |
CN108939171A (zh) * | 2018-08-03 | 2018-12-07 | 孙廷柱 | 一种具有缩阴功能的可溶性安全套及其生产方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102793032A (zh) | 一种养生菌茶及其应用 | |
CN103392937B (zh) | 一种整粒小麦型肉鸡配合饲料及其制备方法 | |
CN103704623B (zh) | 一种玛卡发酵营养食品 | |
CN103392761A (zh) | 一种虎杖红枣保健面包 | |
CN110313530A (zh) | 一种改善男性功能的人参五宝茶及其制备方法 | |
CN105982062A (zh) | 复合杂粮营养食品 | |
CN104397576A (zh) | 一种超微黑木耳粉营养强化粥及其制备方法 | |
KR100725182B1 (ko) | 자생식물 소재를 이용한 건강기능성 맛김 및 그 제조방법 | |
KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
CN104872521A (zh) | 一种有助于提高性生活质量的天然保健食品及其生产工艺 | |
CN104996639A (zh) | 一种黄秋葵花茶的制备方法 | |
CN105010635A (zh) | 一种蒲公英保健袋泡茶及其制备方法 | |
CN101194719B (zh) | 一种芝麻叶绿豆保健面制备方法及其芝麻叶绿豆保健面 | |
CN106071679A (zh) | 一种改善青少年视力的杂粮米糊食品及其制备方法 | |
CN105994740A (zh) | 铁皮石斛绿茶及其制备方法 | |
CN104872649A (zh) | 一种玛咖药食同源食品及其制备方法 | |
KR101200092B1 (ko) | 한방 동자 복숭아 장아찌의 제조방법 | |
KR101834638B1 (ko) | 대추를 주원료로 하는 기능성 다식 제조방법 | |
CN101366422A (zh) | 一种虫草袋泡茶及其生产方法 | |
KR20090104167A (ko) | 유산균이 함유된 김치를 포함하는 녹즙 조성물 | |
CN104911056B (zh) | 一种共发酵法玛咖黄酒及其加工方法 | |
KR101315903B1 (ko) | 전통발효식품을 이용한 슬라이스 식품 및 그 제조방법 | |
CN105029413A (zh) | 玛咖保健组合物 | |
CN105053407A (zh) | 一种火龙果皮甜茶的制备方法 | |
CN104012722A (zh) | 一种松花茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150902 |